Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.
The global market for NSAIDs for Dysmenorrhea is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key NSAIDs for Dysmenorrhea players cover IOLCP, Granules Biocause, Strides Shasun, BASF and SI Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global NSAIDs for Dysmenorrhea market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global NSAIDs for Dysmenorrhea market, with both quantitative and qualitative data, to help readers understand how the NSAIDs for Dysmenorrhea market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the NSAIDs for Dysmenorrhea market and forecasts the market size by Type (Ibuprofen, Celecoxib and Ketoprofen), by Application (Hospital, Clinic, Pharmacy and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Ibuprofen
Celecoxib
Ketoprofen
Others
Segmentation by application
Hospital
Clinic
Pharmacy
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda
Chapter Introduction
Chapter 1: Scope of NSAIDs for Dysmenorrhea, Research Methodology, etc.
Chapter 2: Executive Summary, global NSAIDs for Dysmenorrhea market size (sales and revenue) and CAGR, NSAIDs for Dysmenorrhea market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: NSAIDs for Dysmenorrhea sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global NSAIDs for Dysmenorrhea sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global NSAIDs for Dysmenorrhea market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NSAIDs for Dysmenorrhea Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for NSAIDs for Dysmenorrhea by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for NSAIDs for Dysmenorrhea by Country/Region, 2017, 2022 & 2028
2.2 NSAIDs for Dysmenorrhea Segment by Type
2.2.1 Ibuprofen
2.2.2 Celecoxib
2.2.3 Ketoprofen
2.2.4 Others
2.3 NSAIDs for Dysmenorrhea Sales by Type
2.3.1 Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
2.3.2 Global NSAIDs for Dysmenorrhea Revenue and Market Share by Type (2017-2022)
2.3.3 Global NSAIDs for Dysmenorrhea Sale Price by Type (2017-2022)
2.4 NSAIDs for Dysmenorrhea Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Other
2.5 NSAIDs for Dysmenorrhea Sales by Application
2.5.1 Global NSAIDs for Dysmenorrhea Sale Market Share by Application (2017-2022)
2.5.2 Global NSAIDs for Dysmenorrhea Revenue and Market Share by Application (2017-2022)
2.5.3 Global NSAIDs for Dysmenorrhea Sale Price by Application (2017-2022)
3 Global NSAIDs for Dysmenorrhea by Company
3.1 Global NSAIDs for Dysmenorrhea Breakdown Data by Company
3.1.1 Global NSAIDs for Dysmenorrhea Annual Sales by Company (2020-2022)
3.1.2 Global NSAIDs for Dysmenorrhea Sales Market Share by Company (2020-2022)
3.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Company (2020-2022)
3.2.1 Global NSAIDs for Dysmenorrhea Revenue by Company (2020-2022)
3.2.2 Global NSAIDs for Dysmenorrhea Revenue Market Share by Company (2020-2022)
3.3 Global NSAIDs for Dysmenorrhea Sale Price by Company
3.4 Key Manufacturers NSAIDs for Dysmenorrhea Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers NSAIDs for Dysmenorrhea Product Location Distribution
3.4.2 Players NSAIDs for Dysmenorrhea Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for NSAIDs for Dysmenorrhea by Geographic Region
4.1 World Historic NSAIDs for Dysmenorrhea Market Size by Geographic Region (2017-2022)
4.1.1 Global NSAIDs for Dysmenorrhea Annual Sales by Geographic Region (2017-2022)
4.1.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Geographic Region
4.2 World Historic NSAIDs for Dysmenorrhea Market Size by Country/Region (2017-2022)
4.2.1 Global NSAIDs for Dysmenorrhea Annual Sales by Country/Region (2017-2022)
4.2.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Country/Region
4.3 Americas NSAIDs for Dysmenorrhea Sales Growth
4.4 APAC NSAIDs for Dysmenorrhea Sales Growth
4.5 Europe NSAIDs for Dysmenorrhea Sales Growth
4.6 Middle East & Africa NSAIDs for Dysmenorrhea Sales Growth
5 Americas
5.1 Americas NSAIDs for Dysmenorrhea Sales by Country
5.1.1 Americas NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
5.1.2 Americas NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
5.2 Americas NSAIDs for Dysmenorrhea Sales by Type
5.3 Americas NSAIDs for Dysmenorrhea Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NSAIDs for Dysmenorrhea Sales by Region
6.1.1 APAC NSAIDs for Dysmenorrhea Sales by Region (2017-2022)
6.1.2 APAC NSAIDs for Dysmenorrhea Revenue by Region (2017-2022)
6.2 APAC NSAIDs for Dysmenorrhea Sales by Type
6.3 APAC NSAIDs for Dysmenorrhea Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe NSAIDs for Dysmenorrhea by Country
7.1.1 Europe NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
7.1.2 Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
7.2 Europe NSAIDs for Dysmenorrhea Sales by Type
7.3 Europe NSAIDs for Dysmenorrhea Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa NSAIDs for Dysmenorrhea by Country
8.1.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
8.1.2 Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
8.2 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type
8.3 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of NSAIDs for Dysmenorrhea
10.3 Manufacturing Process Analysis of NSAIDs for Dysmenorrhea
10.4 Industry Chain Structure of NSAIDs for Dysmenorrhea
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 NSAIDs for Dysmenorrhea Distributors
11.3 NSAIDs for Dysmenorrhea Customer
12 World Forecast Review for NSAIDs for Dysmenorrhea by Geographic Region
12.1 Global NSAIDs for Dysmenorrhea Market Size Forecast by Region
12.1.1 Global NSAIDs for Dysmenorrhea Forecast by Region (2023-2028)
12.1.2 Global NSAIDs for Dysmenorrhea Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global NSAIDs for Dysmenorrhea Forecast by Type
12.7 Global NSAIDs for Dysmenorrhea Forecast by Application
13 Key Players Analysis
13.1 IOLCP
13.1.1 IOLCP Company Information
13.1.2 IOLCP NSAIDs for Dysmenorrhea Product Offered
13.1.3 IOLCP NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 IOLCP Main Business Overview
13.1.5 IOLCP Latest Developments
13.2 Granules Biocause
13.2.1 Granules Biocause Company Information
13.2.2 Granules Biocause NSAIDs for Dysmenorrhea Product Offered
13.2.3 Granules Biocause NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Granules Biocause Main Business Overview
13.2.5 Granules Biocause Latest Developments
13.3 Strides Shasun
13.3.1 Strides Shasun Company Information
13.3.2 Strides Shasun NSAIDs for Dysmenorrhea Product Offered
13.3.3 Strides Shasun NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Strides Shasun Main Business Overview
13.3.5 Strides Shasun Latest Developments
13.4 BASF
13.4.1 BASF Company Information
13.4.2 BASF NSAIDs for Dysmenorrhea Product Offered
13.4.3 BASF NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 BASF Main Business Overview
13.4.5 BASF Latest Developments
13.5 SI Group
13.5.1 SI Group Company Information
13.5.2 SI Group NSAIDs for Dysmenorrhea Product Offered
13.5.3 SI Group NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 SI Group Main Business Overview
13.5.5 SI Group Latest Developments
13.6 Hisoar
13.6.1 Hisoar Company Information
13.6.2 Hisoar NSAIDs for Dysmenorrhea Product Offered
13.6.3 Hisoar NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hisoar Main Business Overview
13.6.5 Hisoar Latest Developments
13.7 Pfizer Inc
13.7.1 Pfizer Inc Company Information
13.7.2 Pfizer Inc NSAIDs for Dysmenorrhea Product Offered
13.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Pfizer Inc Main Business Overview
13.7.5 Pfizer Inc Latest Developments
13.8 Teva
13.8.1 Teva Company Information
13.8.2 Teva NSAIDs for Dysmenorrhea Product Offered
13.8.3 Teva NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Teva Main Business Overview
13.8.5 Teva Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan NSAIDs for Dysmenorrhea Product Offered
13.9.3 Mylan NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Apotex
13.10.1 Apotex Company Information
13.10.2 Apotex NSAIDs for Dysmenorrhea Product Offered
13.10.3 Apotex NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apotex Main Business Overview
13.10.5 Apotex Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin NSAIDs for Dysmenorrhea Product Offered
13.11.3 Lupin NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 SANOFI-Aventis
13.12.1 SANOFI-Aventis Company Information
13.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Product Offered
13.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 SANOFI-Aventis Main Business Overview
13.12.5 SANOFI-Aventis Latest Developments
13.13 Boehringer-Ingelheim
13.13.1 Boehringer-Ingelheim Company Information
13.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Offered
13.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Boehringer-Ingelheim Main Business Overview
13.13.5 Boehringer-Ingelheim Latest Developments
13.14 BEC Chemicals
13.14.1 BEC Chemicals Company Information
13.14.2 BEC Chemicals NSAIDs for Dysmenorrhea Product Offered
13.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 BEC Chemicals Main Business Overview
13.14.5 BEC Chemicals Latest Developments
13.15 Shandong Xinhua Pharmaceutical
13.15.1 Shandong Xinhua Pharmaceutical Company Information
13.15.2 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
13.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Shandong Xinhua Pharmaceutical Main Business Overview
13.15.5 Shandong Xinhua Pharmaceutical Latest Developments
13.16 Hengrui Medicine
13.16.1 Hengrui Medicine Company Information
13.16.2 Hengrui Medicine NSAIDs for Dysmenorrhea Product Offered
13.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Hengrui Medicine Main Business Overview
13.16.5 Hengrui Medicine Latest Developments
13.17 Hubei Biocause Heilen Pharmaceutical
13.17.1 Hubei Biocause Heilen Pharmaceutical Company Information
13.17.2 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
13.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Hubei Biocause Heilen Pharmaceutical Main Business Overview
13.17.5 Hubei Biocause Heilen Pharmaceutical Latest Developments
13.18 Zibo Xinhua-PERRIGO Pharmaceutical
13.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Company Information
13.18.2 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
13.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Zibo Xinhua-PERRIGO Pharmaceutical Main Business Overview
13.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Latest Developments
13.19 Zhejiang Jiuzhou
13.19.1 Zhejiang Jiuzhou Company Information
13.19.2 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Offered
13.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Zhejiang Jiuzhou Main Business Overview
13.19.5 Zhejiang Jiuzhou Latest Developments
13.20 Hubei Xunda
13.20.1 Hubei Xunda Company Information
13.20.2 Hubei Xunda NSAIDs for Dysmenorrhea Product Offered
13.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Hubei Xunda Main Business Overview
13.20.5 Hubei Xunda Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. NSAIDs for Dysmenorrhea Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. NSAIDs for Dysmenorrhea Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Ibuprofen
Table 4. Major Players of Celecoxib
Table 5. Major Players of Ketoprofen
Table 6. Major Players of Others
Table 7. Global NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 8. Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
Table 9. Global NSAIDs for Dysmenorrhea Revenue by Type (2017-2022) & ($ million)
Table 10. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2017-2022)
Table 11. Global NSAIDs for Dysmenorrhea Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 13. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Table 14. Global NSAIDs for Dysmenorrhea Revenue by Application (2017-2022)
Table 15. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application (2017-2022)
Table 16. Global NSAIDs for Dysmenorrhea Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global NSAIDs for Dysmenorrhea Sales by Company (2020-2022) & (K Units)
Table 18. Global NSAIDs for Dysmenorrhea Sales Market Share by Company (2020-2022)
Table 19. Global NSAIDs for Dysmenorrhea Revenue by Company (2020-2022) ($ Millions)
Table 20. Global NSAIDs for Dysmenorrhea Revenue Market Share by Company (2020-2022)
Table 21. Global NSAIDs for Dysmenorrhea Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers NSAIDs for Dysmenorrhea Producing Area Distribution and Sales Area
Table 23. Players NSAIDs for Dysmenorrhea Products Offered
Table 24. NSAIDs for Dysmenorrhea Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global NSAIDs for Dysmenorrhea Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global NSAIDs for Dysmenorrhea Sales Market Share Geographic Region (2017-2022)
Table 29. Global NSAIDs for Dysmenorrhea Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global NSAIDs for Dysmenorrhea Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global NSAIDs for Dysmenorrhea Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global NSAIDs for Dysmenorrhea Sales Market Share by Country/Region (2017-2022)
Table 33. Global NSAIDs for Dysmenorrhea Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global NSAIDs for Dysmenorrhea Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 36. Americas NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2022)
Table 37. Americas NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2022)
Table 39. Americas NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 40. Americas NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
Table 41. Americas NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 42. Americas NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Table 43. APAC NSAIDs for Dysmenorrhea Sales by Region (2017-2022) & (K Units)
Table 44. APAC NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2022)
Table 45. APAC NSAIDs for Dysmenorrhea Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC NSAIDs for Dysmenorrhea Revenue Market Share by Region (2017-2022)
Table 47. APAC NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 48. APAC NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
Table 49. APAC NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 50. APAC NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Table 51. Europe NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 52. Europe NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2022)
Table 53. Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2022)
Table 55. Europe NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 56. Europe NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
Table 57. Europe NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 58. Europe NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa NSAIDs for Dysmenorrhea Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of NSAIDs for Dysmenorrhea
Table 68. Key Market Challenges & Risks of NSAIDs for Dysmenorrhea
Table 69. Key Industry Trends of NSAIDs for Dysmenorrhea
Table 70. NSAIDs for Dysmenorrhea Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. NSAIDs for Dysmenorrhea Distributors List
Table 73. NSAIDs for Dysmenorrhea Customer List
Table 74. Global NSAIDs for Dysmenorrhea Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global NSAIDs for Dysmenorrhea Sales Market Forecast by Region
Table 76. Global NSAIDs for Dysmenorrhea Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global NSAIDs for Dysmenorrhea Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas NSAIDs for Dysmenorrhea Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas NSAIDs for Dysmenorrhea Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC NSAIDs for Dysmenorrhea Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC NSAIDs for Dysmenorrhea Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe NSAIDs for Dysmenorrhea Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe NSAIDs for Dysmenorrhea Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa NSAIDs for Dysmenorrhea Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa NSAIDs for Dysmenorrhea Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global NSAIDs for Dysmenorrhea Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global NSAIDs for Dysmenorrhea Sales Market Share Forecast by Type (2023-2028)
Table 88. Global NSAIDs for Dysmenorrhea Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global NSAIDs for Dysmenorrhea Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global NSAIDs for Dysmenorrhea Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global NSAIDs for Dysmenorrhea Sales Market Share Forecast by Application (2023-2028)
Table 92. Global NSAIDs for Dysmenorrhea Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global NSAIDs for Dysmenorrhea Revenue Market Share Forecast by Application (2023-2028)
Table 94. IOLCP Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 95. IOLCP NSAIDs for Dysmenorrhea Product Offered
Table 96. IOLCP NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. IOLCP Main Business
Table 98. IOLCP Latest Developments
Table 99. Granules Biocause Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 100. Granules Biocause NSAIDs for Dysmenorrhea Product Offered
Table 101. Granules Biocause NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Granules Biocause Main Business
Table 103. Granules Biocause Latest Developments
Table 104. Strides Shasun Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 105. Strides Shasun NSAIDs for Dysmenorrhea Product Offered
Table 106. Strides Shasun NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Strides Shasun Main Business
Table 108. Strides Shasun Latest Developments
Table 109. BASF Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 110. BASF NSAIDs for Dysmenorrhea Product Offered
Table 111. BASF NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. BASF Main Business
Table 113. BASF Latest Developments
Table 114. SI Group Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 115. SI Group NSAIDs for Dysmenorrhea Product Offered
Table 116. SI Group NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. SI Group Main Business
Table 118. SI Group Latest Developments
Table 119. Hisoar Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 120. Hisoar NSAIDs for Dysmenorrhea Product Offered
Table 121. Hisoar NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Hisoar Main Business
Table 123. Hisoar Latest Developments
Table 124. Pfizer Inc Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 125. Pfizer Inc NSAIDs for Dysmenorrhea Product Offered
Table 126. Pfizer Inc NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Pfizer Inc Main Business
Table 128. Pfizer Inc Latest Developments
Table 129. Teva Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 130. Teva NSAIDs for Dysmenorrhea Product Offered
Table 131. Teva NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Teva Main Business
Table 133. Teva Latest Developments
Table 134. Mylan Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 135. Mylan NSAIDs for Dysmenorrhea Product Offered
Table 136. Mylan NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Mylan Main Business
Table 138. Mylan Latest Developments
Table 139. Apotex Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 140. Apotex NSAIDs for Dysmenorrhea Product Offered
Table 141. Apotex NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Apotex Main Business
Table 143. Apotex Latest Developments
Table 144. Lupin Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 145. Lupin NSAIDs for Dysmenorrhea Product Offered
Table 146. Lupin NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Lupin Main Business
Table 148. Lupin Latest Developments
Table 149. SANOFI-Aventis Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 150. SANOFI-Aventis NSAIDs for Dysmenorrhea Product Offered
Table 151. SANOFI-Aventis NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. SANOFI-Aventis Main Business
Table 153. SANOFI-Aventis Latest Developments
Table 154. Boehringer-Ingelheim Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 155. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Offered
Table 156. Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Boehringer-Ingelheim Main Business
Table 158. Boehringer-Ingelheim Latest Developments
Table 159. BEC Chemicals Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 160. BEC Chemicals NSAIDs for Dysmenorrhea Product Offered
Table 161. BEC Chemicals NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. BEC Chemicals Main Business
Table 163. BEC Chemicals Latest Developments
Table 164. Shandong Xinhua Pharmaceutical Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 165. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
Table 166. Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Shandong Xinhua Pharmaceutical Main Business
Table 168. Shandong Xinhua Pharmaceutical Latest Developments
Table 169. Hengrui Medicine Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 170. Hengrui Medicine NSAIDs for Dysmenorrhea Product Offered
Table 171. Hengrui Medicine NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 172. Hengrui Medicine Main Business
Table 173. Hengrui Medicine Latest Developments
Table 174. Hubei Biocause Heilen Pharmaceutical Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 175. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
Table 176. Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 177. Hubei Biocause Heilen Pharmaceutical Main Business
Table 178. Hubei Biocause Heilen Pharmaceutical Latest Developments
Table 179. Zibo Xinhua-PERRIGO Pharmaceutical Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 180. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
Table 181. Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 182. Zibo Xinhua-PERRIGO Pharmaceutical Main Business
Table 183. Zibo Xinhua-PERRIGO Pharmaceutical Latest Developments
Table 184. Zhejiang Jiuzhou Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 185. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Offered
Table 186. Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 187. Zhejiang Jiuzhou Main Business
Table 188. Zhejiang Jiuzhou Latest Developments
Table 189. Hubei Xunda Basic Information, NSAIDs for Dysmenorrhea Manufacturing Base, Sales Area and Its Competitors
Table 190. Hubei Xunda NSAIDs for Dysmenorrhea Product Offered
Table 191. Hubei Xunda NSAIDs for Dysmenorrhea Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 192. Hubei Xunda Main Business
Table 193. Hubei Xunda Latest Developments
List of Figures
Figure 1. Picture of NSAIDs for Dysmenorrhea
Figure 2. NSAIDs for Dysmenorrhea Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NSAIDs for Dysmenorrhea Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global NSAIDs for Dysmenorrhea Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. NSAIDs for Dysmenorrhea Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Ibuprofen
Figure 10. Product Picture of Celecoxib
Figure 11. Product Picture of Ketoprofen
Figure 12. Product Picture of Others
Figure 13. Global NSAIDs for Dysmenorrhea Sales Market Share by Type in 2021
Figure 14. Global NSAIDs for Dysmenorrhea Revenue Market Share by Type (2017-2022)
Figure 15. NSAIDs for Dysmenorrhea Consumed in Hospital
Figure 16. Global NSAIDs for Dysmenorrhea Market: Hospital (2017-2022) & (K Units)
Figure 17. NSAIDs for Dysmenorrhea Consumed in Clinic
Figure 18. Global NSAIDs for Dysmenorrhea Market: Clinic (2017-2022) & (K Units)
Figure 19. NSAIDs for Dysmenorrhea Consumed in Pharmacy
Figure 20. Global NSAIDs for Dysmenorrhea Market: Pharmacy (2017-2022) & (K Units)
Figure 21. NSAIDs for Dysmenorrhea Consumed in Other
Figure 22. Global NSAIDs for Dysmenorrhea Market: Other (2017-2022) & (K Units)
Figure 23. Global NSAIDs for Dysmenorrhea Sales Market Share by Application (2017-2022)
Figure 24. Global NSAIDs for Dysmenorrhea Revenue Market Share by Application in 2021
Figure 25. NSAIDs for Dysmenorrhea Revenue Market by Company in 2021 ($ Million)
Figure 26. Global NSAIDs for Dysmenorrhea Revenue Market Share by Company in 2021
Figure 27. Global NSAIDs for Dysmenorrhea Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global NSAIDs for Dysmenorrhea Revenue Market Share by Geographic Region in 2021
Figure 29. Global NSAIDs for Dysmenorrhea Sales Market Share by Region (2017-2022)
Figure 30. Global NSAIDs for Dysmenorrhea Revenue Market Share by Country/Region in 2021
Figure 31. Americas NSAIDs for Dysmenorrhea Sales 2017-2022 (K Units)
Figure 32. Americas NSAIDs for Dysmenorrhea Revenue 2017-2022 ($ Millions)
Figure 33. APAC NSAIDs for Dysmenorrhea Sales 2017-2022 (K Units)
Figure 34. APAC NSAIDs for Dysmenorrhea Revenue 2017-2022 ($ Millions)
Figure 35. Europe NSAIDs for Dysmenorrhea Sales 2017-2022 (K Units)
Figure 36. Europe NSAIDs for Dysmenorrhea Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa NSAIDs for Dysmenorrhea Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa NSAIDs for Dysmenorrhea Revenue 2017-2022 ($ Millions)
Figure 39. Americas NSAIDs for Dysmenorrhea Sales Market Share by Country in 2021
Figure 40. Americas NSAIDs for Dysmenorrhea Revenue Market Share by Country in 2021
Figure 41. United States NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC NSAIDs for Dysmenorrhea Sales Market Share by Region in 2021
Figure 46. APAC NSAIDs for Dysmenorrhea Revenue Market Share by Regions in 2021
Figure 47. China NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 51. India NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia NSAIDs for Dysmenorrhea Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe NSAIDs for Dysmenorrhea Sales Market Share by Country in 2021
Figure 54. Europe NSAIDs for Dysmenorrhea Revenue Market Share by Country in 2021
Figure 55. Germany NSAIDs for Dysmenorrhea Revenue Growth
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)